JMIR mHealth and uHealth · 2025
Use of Wearable Sensors to Assess Fall Risk in Neurological Disorders: Systematic Review.
СтатьяСистематический обзорНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Bonanno Mirjam, Ielo Augusto, De Pasquale Paolo, Celesti Antonio, De Nunzio Alessandro Marco, Quartarone Angelo, Calabrò Rocco Salvatore
Аннотация
BACKGROUND: Assessing fall risk, especially in individuals with neurological disorders, is essential to prevent hospitalization, hypomobility, and reduced functional independence. Wearable sensors are increasingly used in neurorehabilitation, as they enable unsupervised fall risk assessment by providing continuous monitoring during daily functional tasks, thereby offering a reflection of the individual's real-world fall risk.
OBJECTIVE: We systematically reviewed the literature on reliable biomechanical gait parameters detected with wearable sensors to assess fall risk in neurological disorders, focusing on patients with Parkinson disease, multiple sclerosis, stroke, or Alzheimer disease. In addition, we examined the latest advancements in wearable sensor technology, including best practices for device placement as well as data processing and analysis.
METHODS: We conducted a comprehensive systematic search for relevant peer-reviewed articles published up to April 18, 2025, using PubMed, Web of Science, Embase, and IEEE Xplore, which are the most used databases in the fields of health and bioengineering.
RESULTS: The 19 included studies involved 2630 patients with neurological disorders, including 226 (8.59%) with multiple sclerosis (n=7, 37% studies), 2305 (87.64%) with Parkinson disease (n=8, 53% studies), 51 (1.94%) with stroke (n=3, 16% studies), and 48 (1.83%) with Alzheimer disease or cognitive impairment (n=1, 5% study).
CONCLUSIONS: This review highlights the role of wearable technologies in assessing fall risk in patients with neurological disorders. Although the included studies showed variation in methods and a focus on technology over clinical context, the lack of standardization reflects ongoing advancements, which may be seen as a strength.
TRIAL REGISTRATION: PROSPERO CRD42023463944; https://www.crd.york.ac.uk/PROSPERO/view/CRD42023463944.
OBJECTIVE: We systematically reviewed the literature on reliable biomechanical gait parameters detected with wearable sensors to assess fall risk in neurological disorders, focusing on patients with Parkinson disease, multiple sclerosis, stroke, or Alzheimer disease. In addition, we examined the latest advancements in wearable sensor technology, including best practices for device placement as well as data processing and analysis.
METHODS: We conducted a comprehensive systematic search for relevant peer-reviewed articles published up to April 18, 2025, using PubMed, Web of Science, Embase, and IEEE Xplore, which are the most used databases in the fields of health and bioengineering.
RESULTS: The 19 included studies involved 2630 patients with neurological disorders, including 226 (8.59%) with multiple sclerosis (n=7, 37% studies), 2305 (87.64%) with Parkinson disease (n=8, 53% studies), 51 (1.94%) with stroke (n=3, 16% studies), and 48 (1.83%) with Alzheimer disease or cognitive impairment (n=1, 5% study).
CONCLUSIONS: This review highlights the role of wearable technologies in assessing fall risk in patients with neurological disorders. Although the included studies showed variation in methods and a focus on technology over clinical context, the lack of standardization reflects ongoing advancements, which may be seen as a strength.
TRIAL REGISTRATION: PROSPERO CRD42023463944; https://www.crd.york.ac.uk/PROSPERO/view/CRD42023463944.